日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O8 30S ribosomal protein S21 (rpsU) CSB-YP486799EOO
CSB-EP486799EOO
CSB-BP486799EOO
CSB-MP486799EOO
CSB-EP486799EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Voltage-gated ClC-type chloride channel ClcB (clcB), partial CSB-YP486800EOO
CSB-EP486800EOO
CSB-BP486800EOO
CSB-MP486800EOO
CSB-EP486800EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 D-tagatose-1,6-bisphosphate aldolase subunit KbaY (kbaY) CSB-YP486801EOO
CSB-EP486801EOO
CSB-BP486801EOO
CSB-MP486801EOO
CSB-EP486801EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Ribosome-binding factor A (rbfA) CSB-YP486802EOO
CSB-EP486802EOO
CSB-BP486802EOO
CSB-MP486802EOO
CSB-EP486802EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 GTPase obg (obg) CSB-YP486803EOO
CSB-EP486803EOO
CSB-BP486803EOO
CSB-MP486803EOO
CSB-EP486803EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Chaperone protein DnaJ (dnaJ) CSB-YP486804EOO
CSB-EP486804EOO
CSB-BP486804EOO
CSB-MP486804EOO
CSB-EP486804EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Protein fixA (fixA) CSB-YP486805EOO
CSB-EP486805EOO
CSB-BP486805EOO
CSB-MP486805EOO
CSB-EP486805EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 DNA replication terminus site-binding protein (tus) CSB-YP486806EOO
CSB-EP486806EOO
CSB-BP486806EOO
CSB-MP486806EOO
CSB-EP486806EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Electron transport complex protein RnfD (rnfD), partial CSB-YP486807EOO
CSB-EP486807EOO
CSB-BP486807EOO
CSB-MP486807EOO
CSB-EP486807EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Putative sialic acid transporter (nanT), partial CSB-YP486808EOO
CSB-EP486808EOO
CSB-BP486808EOO
CSB-MP486808EOO
CSB-EP486808EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 p-hydroxybenzoic acid efflux pump subunit AaeA (aaeA), partial CSB-YP486809EOO1
CSB-EP486809EOO1
CSB-BP486809EOO1
CSB-MP486809EOO1
CSB-EP486809EOO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 30S ribosomal protein S11 (rpsK) CSB-YP486810EOO
CSB-EP486810EOO
CSB-BP486810EOO
CSB-MP486810EOO
CSB-EP486810EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP486811EOO
CSB-EP486811EOO
CSB-BP486811EOO
CSB-MP486811EOO
CSB-EP486811EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 GMP reductase (guaC) CSB-YP486812EOO
CSB-EP486812EOO
CSB-BP486812EOO
CSB-MP486812EOO
CSB-EP486812EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Sugar fermentation stimulation protein A (sfsA) CSB-YP486813EOO
CSB-EP486813EOO
CSB-BP486813EOO
CSB-MP486813EOO
CSB-EP486813EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP486814EOO
CSB-EP486814EOO
CSB-BP486814EOO
CSB-MP486814EOO
CSB-EP486814EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Vitamin B12 import ATP-binding protein BtuD (btuD) CSB-YP486815EOO
CSB-EP486815EOO
CSB-BP486815EOO
CSB-MP486815EOO
CSB-EP486815EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Succinylornithine transaminase (astC) CSB-YP486816EOO
CSB-EP486816EOO
CSB-BP486816EOO
CSB-MP486816EOO
CSB-EP486816EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 30S ribosomal protein S14 (rpsN) CSB-YP486817EOO
CSB-EP486817EOO
CSB-BP486817EOO
CSB-MP486817EOO
CSB-EP486817EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 50S ribosomal protein L16 (rplP) CSB-YP486818EOO
CSB-EP486818EOO
CSB-BP486818EOO
CSB-MP486818EOO
CSB-EP486818EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×